Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply
Lancet Oncol
.
2017 Dec;18(12):e709-e710.
doi: 10.1016/S1470-2045(17)30856-2.
Authors
Michael Weller
1
,
Nicholas Butowski
2
,
David D Tran
3
,
Lawrence D Recht
4
,
Michael Lim
5
,
Hal Hirte
6
,
Lynn Ashby
7
,
Laszlo Mechtler
8
,
Samuel A Goldlust
9
,
Fabio Iwamoto
10
,
Jan Drappatz
11
,
Donald M O'Rourke
12
,
Mark Wong
13
,
Mark G Hamilton
14
,
Gaetano Finocchiaro
15
,
James Perry
16
,
Wolfgang Wick
17
,
Jennifer Green
18
,
Yi He
18
,
Christopher D Turner
18
,
Michael J Yellin
18
,
Tibor Keler
18
,
Thomas A Davis
18
,
Roger Stupp
19
,
John H Sampson
20
Affiliations
1
Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address:
[email protected]
.
2
Department of Neurological Surgery, University of California, San Francisco, CA, USA.
3
Washington University, St Louis, MO, USA.
4
Stanford University Medical Center, Palo Alto, CA, USA.
5
The Johns Hopkins Hospital, Baltimore, MD, USA.
6
Juravinski Cancer Centre, Hamilton, ON, Canada.
7
Barrow Neurological Institute, Phoenix, AZ, USA.
8
DENT Neurologic Institute, Buffalo, NY, USA.
9
John Theurer Cancer Center, Hackensack, NJ, USA.
10
Columbia University Medical Center, New York, NY, USA.
11
University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
12
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
13
Westmead Hospital, Westmead, NSW, Australia.
14
University of Calgary, Department of Clinical Neurosciences, Division of Neurosurgery, Foothills Hospital, Calgary, AB, Canada.
15
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
16
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
17
The University of Heidelberg and German Cancer Research Center, Heidelberg, Germany.
18
Celldex Therapeutics, Inc, Hampton, NJ, USA.
19
Department of Oncology, University Hospital and University of Zurich, Zurich, Switzerland.
20
The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
PMID:
29208433
DOI:
10.1016/S1470-2045(17)30856-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Clinical Trials, Phase III as Topic*
Decision Making*